These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4542571)

  • 1. [Clinical evaluation in 42 rheumatic patients of a new pyrazole derivative: pyrazinobutazone or Carudol].
    Delhaye JP; Famaey JP
    J Dent Assoc S Afr; 1973; 28(1):14-22. PubMed ID: 4542571
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anti-inflammatory clinical effects of pyrazinobutazone (study of 44 cases with principally rheumatologic indications)].
    Le Chevallier PL
    Rhumatologie; 1972 Mar; 24(3):91-100. PubMed ID: 4538813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of pyrazinobutazone in the treatment of different inflammatory states].
    Gaillarde B; Ortonne JP; Pugeat M; Plauchu M
    J Med Lyon; 1972 Oct; 53(234):1315-6 passim. PubMed ID: 4539046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Midalgyl in rheumatology. Study on 50 patients].
    Laborie G
    Bord Med; 1971 Sep; 4(9):2471-2 passim. PubMed ID: 5315933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pyrazinobutazone in rheumatology (Clinical study of 50 cases)].
    Fournie A; Ayrolles C
    Rhumatologie; 1972; 24(7):287-91. PubMed ID: 4540383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation].
    Gerhold H
    Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new drug combination in rheumatology].
    Buoniconti A; Ruiz SI; D'Auria H; Cobra CJ
    Hospital (Rio J); 1965 Apr; 67(4):783-8. PubMed ID: 5294228
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect].
    Capretti G; Marinoni C
    Clin Ter; 1974 Feb; 68(3):233-45. PubMed ID: 4596251
    [No Abstract]   [Full Text] [Related]  

  • 9. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
    Weissenbach R
    Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent acquisitions in anti-inflammatory therapy in rheumatology].
    Saporta L; Massias P
    Therapeutique; 1970 Nov; 46(9):937-9. PubMed ID: 5486145
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of a new anti-inflammatory agent in rheumatology, ANP 3260 or clofezone].
    Verhaeghe A; Lesage R; Delcambre B
    Lille Med; 1968 Mar; 13(3):Suppl:260-5. PubMed ID: 4927184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Association of a new analgesic with phenylbutazone in rheumatic diseases].
    Fellet AJ; Meyer JA
    Hospital (Rio J); 1966 Oct; 70(4):1009-15. PubMed ID: 5301478
    [No Abstract]   [Full Text] [Related]  

  • 13. [A.N.P. 3260 in rheumatology].
    Vignon G; Falconnet M; Cibert M
    Rev Lyon Med; 1967 Oct; 16(15):627-31. PubMed ID: 5311741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with a new phenylbutazone preparation: Alka-Butazolidine].
    Porzio F; Tuzi T
    Rass Int Clin Ter; 1972 May; 52(10):583-90. PubMed ID: 4537829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of rheumatic diseases with a new antirheumatism drug: isopyrine hydrochloride and phebuzine].
    Debes AC; Federico W; Spilborghs G
    Rev Bras Med; 1965 Jul; 22(7):443-4. PubMed ID: 5321989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nonsteroid anti-inflammatory agents. Value of equimolecular salt of phenylbutazone and piperazine in the treatment of rheumatic diseases].
    Delbarre F
    Therapeutique; 1971 Mar; 47(3):231-5. PubMed ID: 5314703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases].
    Kogstad O
    Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic use of clofezone in rheumatic diseases].
    Vitaus M; Franovic A; Dürrigl T
    Schweiz Rundsch Med Prax; 1973 Jan; 62(3):78-82. PubMed ID: 4282506
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
    Pipino F; Franchin F
    Minerva Med; 1980 Oct; 71(39):2845-50. PubMed ID: 7001282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with an indomethacin-phenylbutazone combination in various rheumatic diseases].
    Hernández Peńa M
    Rev Esp Reum Enferm Osteoartic; 1973; 16(2):111-31. PubMed ID: 4541698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.